HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salivary cortisol and dehydroepiandrosterone sulphate levels in postmenopausal women with primary breast cancer.

Abstract
Cortisol and dehydroepiandrosterone sulphate (DHAS) were measured in saliva from postmenopausal women with primary breast cancer and a control group of comparable age. Specimens were collected at 2-hr intervals during wake-span for two consecutive days, and circadian rhythmicity was demonstrated for each of the hormones in both populations. The marginally elevated levels of cortisol and lower levels of DHAS associated with the cancer group, and the larger inter-subject variation, make it unlikely that these hormone measurements would be of value in identifying women at risk of developing breast cancer.
AuthorsG F Read, D W Wilson, F C Campbell, H W Holliday, R W Blamey, K Griffiths
JournalEuropean journal of cancer & clinical oncology (Eur J Cancer Clin Oncol) Vol. 19 Issue 4 Pg. 477-83 (Apr 1983) ISSN: 0277-5379 [Print] England
PMID6222900 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dehydroepiandrosterone
  • Dehydroepiandrosterone Sulfate
  • Hydrocortisone
Topics
  • Aged
  • Breast Neoplasms (metabolism)
  • Circadian Rhythm
  • Dehydroepiandrosterone (analogs & derivatives, analysis)
  • Dehydroepiandrosterone Sulfate
  • Female
  • Humans
  • Hydrocortisone (analysis)
  • Menopause
  • Middle Aged
  • Risk
  • Saliva (analysis)
  • Statistics as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: